These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10962220)

  • 1. Inverse correlation between hallucinations and serum prolactin in patients with non-affective psychoses.
    Appleberg B; Katila H; Rimón R
    Schizophr Res; 2000 Sep; 44(3):183-6. PubMed ID: 10962220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of psychotic symptoms to haloperidol-stimulated prolactin release.
    Kulkarni J; Keks NA; Stuart G; Mackie B; Minas IH; Singh BS; Copolov DL
    Acta Psychiatr Scand; 1990 Oct; 82(4):271-4. PubMed ID: 2260479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin response to submaximal stimulation by TRH in nonaffective psychoses.
    Spoov J; Bredbacka PE; Appelberg B; Katila H; Karonen SL; Rimón R; Sarna S
    Biol Psychiatry; 1991 Feb; 29(3):204-10. PubMed ID: 1673063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders.
    Cassano GB; Pini S; Saettoni M; Rucci P; Dell'Osso L
    J Clin Psychiatry; 1998 Feb; 59(2):60-8. PubMed ID: 9501887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of resistance to voices on depression].
    Monestès JL; Vavasseur-Desperriers J; Villatte M; Denizot L; Loas G; Rusinek S
    Encephale; 2015 Feb; 41(1):25-31. PubMed ID: 24815790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum prolactin response to chlorpromazine and psychopathology in schizophrenics: implications for the dopamine hypothesis.
    Meltzer HY; Busch D
    Psychiatry Res; 1983 Aug; 9(4):285-99. PubMed ID: 6580661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. REM sleep and prolactin in patients with non-affective psychoses.
    Appelberg B; Katila H; Rimón R
    Psychoneuroendocrinology; 2002 Aug; 27(6):661-9. PubMed ID: 12084659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis abuse and severity of psychotic and affective disorders in Israeli psychiatric inpatients.
    Katz G; Durst R; Shufman E; Bar-Hamburger R; Grunhaus L
    Compr Psychiatry; 2010; 51(1):37-41. PubMed ID: 19932824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiety symptoms in schizophrenia spectrum disorders: associations with social function, positive and negative symptoms, hope and trauma history.
    Lysaker PH; Salyers MP
    Acta Psychiatr Scand; 2007 Oct; 116(4):290-8. PubMed ID: 17803759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptom dimensions in acutely ill patients with affective, schizoaffective, and schizophrenic disorders.
    Fleck DE; Corey KB; Strakowski SM
    Schizophr Res; 2001 May; 50(1-2):131-2. PubMed ID: 11378321
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis and evaluation of hallucinations and other psychotic symptoms in children and adolescents.
    Sikich L
    Child Adolesc Psychiatr Clin N Am; 2013 Oct; 22(4):655-73. PubMed ID: 24012079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS).
    Haddock G; McCarron J; Tarrier N; Faragher EB
    Psychol Med; 1999 Jul; 29(4):879-89. PubMed ID: 10473315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of affective domains within the nonaffective psychotic disorders.
    Peralta V; Cuesta MJ
    Schizophr Res; 2009 Jun; 111(1-3):61-9. PubMed ID: 19321311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizoaffective disorder: a form of schizophrenia or affective disorder?
    Evans JD; Heaton RK; Paulsen JS; McAdams LA; Heaton SC; Jeste DV
    J Clin Psychiatry; 1999 Dec; 60(12):874-82. PubMed ID: 10665641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum prolactin correlates with depressed mood during alcohol withdrawal.
    Miller F; Barasch A; Sacks M; Levitan J; Ashcroft L
    Drug Alcohol Depend; 1986 Jul; 17(4):331-8. PubMed ID: 3757769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and psychometric validation of the psychotic depression assessment scale.
    Østergaard SD; Pedersen CH; Uggerby P; Munk-Jørgensen P; Rothschild AJ; Larsen JI; Gøtzsche C; Søndergaard MG; Bille AG; Bolwig TG; Larsen JK; Bech P
    J Affect Disord; 2015 Mar; 173():261-8. PubMed ID: 25462426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sociodemographic and clinical correlates of psychotic symptoms in the general population: Findings from the MHGP survey.
    Pignon B; Schürhoff F; Szöke A; Geoffroy PA; Jardri R; Roelandt JL; Rolland B; Thomas P; Vaiva G; Amad A
    Schizophr Res; 2018 Mar; 193():336-342. PubMed ID: 28689754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence of negative symptoms in early schizophrenia, mania and other psychoses.
    Montague LR; Tantam D; Newby D; Thomas P; Ring N
    Acta Psychiatr Scand; 1989 Jun; 79(6):613-8. PubMed ID: 2763854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms.
    Meltzer HY; Kolakowska T; Fang VS; Fogg L; Robertson A; Lewine R; Strahilevitz M; Busch D
    Arch Gen Psychiatry; 1984 May; 41(5):512-9. PubMed ID: 6721674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hallucinations in schizophrenia.
    Mueser KT; Bellack AS; Brady EU
    Acta Psychiatr Scand; 1990 Jul; 82(1):26-9. PubMed ID: 2399817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.